• Human iPSC Hepatobiliary Organoids: Study Insights

  2026-09-07

  Wu et al. developed a staged, three-dimensional system that generates hepatobiliary organoids from human induced pluripotent stem cells without exogenous support cells or genetic manipulation. The resulting organoids reproduced several hepatocyte and cholangiocyte functions, providing a useful platform for studying liver development, drug metabolism, and regenerative medicine.

• GW 6471: Turning PPARα Antagonism into Insight

  2026-09-07

  PPARα biology sits at the intersection of lipid handling, hepatotoxicity, and metabolic disease. This thought-leadership article examines how GW 6471 can help translational researchers distinguish receptor-dependent effects from downstream association, using PFHxS-induced liver injury in zebrafish as a mechanistic anchor. It also outlines a disciplined workflow, clarifies what can and cannot be translated across models, and positions pharmacological antagonism as a strategic complement to transcriptomics, biochemical testing, and genetic perturbation.

• c-Myc Peptide for Immunoassay Workflows

  2026-09-05

  Use the c-Myc Peptide as a sequence-specific competition reagent to validate antibody binding, release tagged fusion proteins, and distinguish epitope-dependent signal from nonspecific capture. This workflow also provides a disciplined bridge to transcription-factor studies inspired by selective autophagy control of IRF3, without confusing an assay control with a biological mechanism.

• HHV-7 DNA in Ocular Toxoplasmosis

  2026-09-04

  Miyase et al. detected human herpesvirus 7 and Toxoplasma gondii DNA together in vitreous humor from a patient with recurrent, treatment-refractory ocular toxoplasmosis. The case highlights multiplex PCR during vitrectomy as a clinically informative diagnostic strategy while suggesting, but not proving, that HHV-7 reactivation may contribute to persistent infectious uveitis.

• HRP Goat Anti-Mouse IgG (H+L) Antibody

  2026-09-04

  This reagent provides an HRP-based detection step for mouse-derived primary antibodies in Western blotting, ELISA, IHC, and ICC. It should not be used as a default secondary for non-mouse primary antibodies, and assay-specific titration is required because the dossier does not provide a universal working dilution or incubation condition.

• Hydroxychloroquine Sulfate: Workflow Guide

  2026-09-03

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible tool for investigating TLR7/9 signaling and autophagy pathway modulation in autoimmune disease research. It is suited to short-term, water-based assays but should not be selected for DMSO- or ethanol-based stocks or workflows requiring long-term storage of prepared solutions.

• Cycloastragenol Protects Against Steroid-Induced ONFH

  2026-09-03

  This in vivo study shows that cycloastragenol reduced femoral-head necrosis and trabecular bone loss in a methylprednisolone-induced rat model by suppressing osteoclast activity. Its significance lies in connecting osteoclast regulation, local blood-supply changes, and structural preservation within a glucocorticoid-induced osteonecrosis framework.

• ISR and Accelerated Forgetting in Epilepsy

  2026-09-02

  A 2025 Molecular Neurobiology study identifies integrated stress response activation as a molecular feature of both natural forgetting and seizure-associated accelerated forgetting in mice. Repeated ISRIB treatment during memory retention prevented recognition-memory loss, whereas a single injection did not alter retrieval, highlighting the importance of treatment timing and memory-maintenance biology.

• Primary Antibody Dilution Buffer for PCNSL Assays

  2026-09-02

  Translate single-cell PCNSL findings into cleaner tissue, cellular, and RNA-localization assays with a BSA- and Triton X-100-containing antibody dilution buffer. This workflow separates product-supported handling from assay conditions that require local validation.

• Fingolimod (FTY720) in Cell Assay Workflows

  2026-09-01

  This scenario-based guide explains how Fingolimod (FTY720), SKU A8548, can be integrated into cell viability, proliferation, cytotoxicity, and trafficking experiments without confusing receptor pharmacology with cell killing. It connects quantitative product data with practical controls for dosing, stock preparation, interpretation, and vendor selection.

• Z-IETD-FMK: Caspase-8 Inhibitor Guide

  2026-09-01

  Z-IETD-FMK, also known as Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone, is an irreversible caspase-8 inhibitor for apoptosis and immune-signaling research. Product data support applications in activated T cell assays, TRAIL pathway studies, and selected in vivo inflammation models.

• Radioiodinated Balsalazide for UC Imaging

  2026-08-31

  The reference study developed and evaluated radioiodinated balsalazide as a colon-directed tracer for imaging ulcerative colitis in mice. Its optimized labeling conditions, 24-hour stability assessment, and markedly higher uptake in ulcerated colon provide a useful framework for preclinical inflammation research, while also highlighting important limits in receptor interpretation and translation to human imaging.

• Prednisone B2148: Reproducible Cell Assay Workflows

  2026-08-31

  This scenario-driven guide explains how Prednisone, SKU B2148, can support reproducible lymphocyte viability, proliferation, cell-cycle, and apoptosis experiments. It focuses on mechanism-aware assay design, DMSO handling, storage, interpretation, and practical vendor evaluation.

• Lenalidomide (CC-5013): A Mechanism-First Guide

  2026-08-30

  Lenalidomide (CC-5013) is an immunomodulatory research compound whose effects span cytokine control, immune synapse formation, angiogenesis, and direct myeloma-cell suppression. This mechanism-first guide translates recent DOT1L–innate immunity findings into practical assay design, controls, and interpretation strategies.

• Cyclic di-GMP as an Antitoxin in Biofilms

  2026-08-29

  The 2024 eLife study identifies cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Its findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, refining models of biofilm resilience and suggesting practical designs for persistence research.

8326 records 1/556 page Next 12345 下5页 Last page